ARTICLE | Company News
Biopharm, Scil Biomedicals deal
April 23, 2001 7:00 AM UTC
The companies will jointly develop a product to regenerate bone in dental and maxillofacial surgery. The product is based on Biopharm's MP52, a member of the transforming growth factor-beta (TGF-beta)...